These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 36737790)

  • 21. An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterparts.
    Tauziède-Espariat A; Sievers P; Larousserie F; Benzakoun J; Guillemot D; Pierron G; Duchesne M; Uro-Coste E; Roux A; Vasiljevic A; Fenouil T; Meyronet D; Mokhtari K; Polivka M; Rousseau A; Bost-Bezeaud F; Akoury S; Pallud J; Benevello C; Hasty L; Gareton A; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Puget S; Sahm F; Varlet P;
    Brain Pathol; 2022 Jan; 32(1):e13010. PubMed ID: 34314078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Embryonal and non-meningothelial mesenchymal tumors of the central nervous system - Advances in diagnosis and prognostication.
    Meredith DM; Alexandrescu S
    Brain Pathol; 2022 Jul; 32(4):e13059. PubMed ID: 35266242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rare embryonal and sarcomatous central nervous system tumours: State-of-the art and future directions.
    Gojo J; Kjaersgaard M; Zezschwitz BV; Capper D; Tietze A; Kool M; Haberler C; Pizer B; Hoff KV
    Eur J Med Genet; 2023 Jan; 66(1):104660. PubMed ID: 36356895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DICER1 mutations in primary central nervous system tumors: new insights into histologies, mutations, and prognosis.
    Liu KX; Shang HH; Cacciotti C; Everdell E; Aizer AA; Rahman R; Malinowski S; Meredith DM; Kamihara J; Wen PY; Ligon KL; Chi SN; Marcus KJ; Yeo KK; Alexandrescu S; Haas-Kogan DA
    J Neurooncol; 2022 May; 157(3):499-510. PubMed ID: 35384518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. World Health Organization Classification of Tumors of the Central Nervous System 5
    Mahajan S; Suri V; Sahu S; Sharma MC; Sarkar C
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S5-S13. PubMed ID: 35562129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An update on the central nervous system manifestations of DICER1 syndrome.
    de Kock L; Priest JR; Foulkes WD; Alexandrescu S
    Acta Neuropathol; 2020 Apr; 139(4):689-701. PubMed ID: 30953130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
    Louis DN; Perry A; Wesseling P; Brat DJ; Cree IA; Figarella-Branger D; Hawkins C; Ng HK; Pfister SM; Reifenberger G; Soffietti R; von Deimling A; Ellison DW
    Neuro Oncol; 2021 Aug; 23(8):1231-1251. PubMed ID: 34185076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of histone H3 trimethylation on lysine 27 and nuclear expression of transducin-like enhancer 1 in primary intracranial sarcoma, DICER1-mutant.
    Alexandrescu S; Meredith DM; Lidov HG; Alaggio R; Novello M; Ligon KL; Vargas SO
    Histopathology; 2021 Jan; 78(2):265-275. PubMed ID: 32692439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newly Recognized Genetic Tumor Syndromes of the CNS in the 5th WHO Classification: Imaging Overview with Genetic Updates.
    Agarwal A; Bathla G; Soni N; Desai A; Ajmera P; Rao D; Gupta V; Vibhute P
    AJNR Am J Neuroradiol; 2024 Feb; 45(2):128-138. PubMed ID: 37945522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
    Bale TA; Rosenblum MK
    Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DICER1-associated central nervous system sarcoma with neural lineage differentiation: a case report.
    Yao K; Duan Z; Feng J; Yan C; Qi X
    Diagn Pathol; 2022 Sep; 17(1):72. PubMed ID: 36153506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic DNA methylome profiling and the WHO 5
    Frank S; Hench J
    Clin Neuropathol; 2022; 41(4):153-156. PubMed ID: 35670246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy.
    Fuller CE; Jones DTW; Kieran MW
    Am Soc Clin Oncol Educ Book; 2017; 37():753-763. PubMed ID: 28561665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Miscellaneous newly recognized types of CNS tumors in the WHO CNS5 classification (other than gliomas, glioneuronal and embryonal tumors).
    Chatterjee D; Gupta K
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S94-S98. PubMed ID: 35562139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary Intracranial Sarcoma, DICER1-Mutant Presenting as a Pineal Region Tumor Mimicking Pineoblastoma: Case Report and Review of the Literature.
    Leelatian N; Goss J; Pastakia D; Dewan MC; Snuderl M; Mobley BC
    J Neuropathol Exp Neurol; 2022 Aug; 81(9):762-764. PubMed ID: 35789272
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular neuropathology: an essential and evolving toolbox for the diagnosis and clinical management of central nervous system tumors.
    Bertero L; Mangherini L; Ricci AA; Cassoni P; Sahm F
    Virchows Arch; 2024 Feb; 484(2):181-194. PubMed ID: 37658995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The World Health Organization Classification of Tumors of the Central Nervous System, Fifth Edition, 2021: A Critical Analysis.
    Miller DC
    Adv Tech Stand Neurosurg; 2023; 46():1-21. PubMed ID: 37318567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathologic "Evolution" in Pediatric Primary Intracranial High-Grade Sarcoma - a Key that Unlocked the Correct Diagnosis.
    Naik U; Shah M; Sandberg DI; Samant R; Roy A; Bhattacharjee MB
    Ann Clin Lab Sci; 2023 Jul; 53(4):661-666. PubMed ID: 37625831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes to pediatric brain tumors in 2021 World Health Organization classification of tumors of the central nervous system.
    Oztek MA; Noda SM; Romberg EK; Cole BL; Wright JN; Ishak GE; Perez FA
    Pediatr Radiol; 2023 Mar; 53(3):523-543. PubMed ID: 36348014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two cases of primary supratentorial intracranial rhabdomyosarcoma with DICER1 mutation which may belong to a "spindle cell sarcoma with rhabdomyosarcoma-like feature, DICER1 mutant".
    Sakaguchi M; Nakano Y; Honda-Kitahara M; Kinoshita M; Tanaka S; Oishi M; Noguchi K; Fukuda M; Maeba H; Watanabe T; Hayashi Y; Ikeda H; Minato H; Ichimura K; Nojima T; Nakada M
    Brain Tumor Pathol; 2019 Oct; 36(4):174-182. PubMed ID: 31487013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.